Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCYNEXIS INC Director's Dealing 2015

Sep 18, 2015

34648_dirs_2015-09-18_dc63acc8-a73b-4cf8-82af-a10becb4833b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2015-09-15

Reporting Person: Angulo Gonzalez David (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-15 Common Stock P 3000 $7 Acquired 3000 Direct